MBX-2982

Generic Name: MBX-2982

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₂₄N_₈OS

CAS Number: 1037792-44-1

Unique Ingredient Identifier: B5TRY67L51

Background: MBX-2982 has been used in trials studying the treatment of Diabetes.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes

Phase 2

Completed

Conditions: Diabetes

Interventions: Drug: MBX-2982
Drug: placebo
Drug: Sitagliptin

First Posted Date: 2009-12-21

Last Posted Date: 2015-04-17

Lead Sponsor: CymaBay Therapeutics, Inc.

Target Recruit Count: 100

Registration Number: NCT01035879

Locations: 🇺🇸
Impact Clinical Trials, Los Angeles, California, United States
🇺🇸
dgd Research, Inc., a Cetero Research Co., San Antonio, Texas, United States
🇺🇸
United Medical Associates, Binghamton, New York, United States

and more 11 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy